Association of Cardiometabolic Disorders with Prostate Cancer Risk: Insights from the PLCO Cancer Screening Study - Top-Institutions - MDSpire

Association of Cardiometabolic Disorders with Prostate Cancer Risk: Insights from the PLCO Cancer Screening Study

  • By

  • Qian Zhu

  • Lan Zeng

  • Menghui Chen

  • April 29, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Oncology
    • Epidemiology
    • Cardiometabolic Disease Research

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Urology
    • Oncology
    • Cardiometabolic Research

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology
    • Cardiology
    • Endocrinology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cancer Research
    • Epidemiology
    • Metabolic Disease

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Cardiology
    • Epidemiology

Original Source(s)

Association of Cardiometabolic Disorders with Prostate Cancer Risk: Insights from the PLCO Cancer Screening Study

  • by Qian Zhu, Lan Zeng, Menghui Chen

  • April 29, 2026

Related Content

A County-Level Index for Cardiovascular Mortality Based on Social Determinants to Identify High-Risk Areas in the United States

Deep learning-based brain age predicts stroke recurrence in acute ischemic cerebrovascular disease

Control Tower in the hospital: a structure–process–outcome systemic review of telemedicine systems for interprofessional collaboration